For quarterly updates on PD clinical trials of drug therapies, visit the new 'Trial Dashboards' feature on pdtrialtracker.info/trial-dashboar…. See new trials, completed trials, published results and more. Feedback and suggestions welcome! Thank you to Kenneth Pitzer for his work on this!

Bringing Advanced Therapies for Parkinson’s Disease to Clinic:Patient’s Perspective. Bringing these treatments will require an informed and empowered patient community. Jon Stamford PD Avengers
content.iospress.com/articles/journ…

Inspired by your work on patient advocacy, Bettina Ryll. Thank you!

Latest update to PDTrialTracker.info now available. Pipeline snapshot shows # active PD trials on ClinicalTrials.gov = 75 Phase 1, 109 Phase 2, and 39 Phase 3. Look forward to time when patient advocates serve on steering committees for all trials.🌷 @PDAvengers

This is what we do: prioritise/support the best research & clinical trials to ID & prove a cure. ASAP. Amazing stat: 35% of potentially curative trials identified were prioritised by Cure Parkinson's iLCT program! We're punching: raising funds to support more, to find a cure.

Suggestions for enhancements to the report to include in 2021 version are most welcome!

Thank you, Cure Parkinson's and Van Andel Institute (VAI), for hosting such an informative and inspiring event. Speakers were amazing and attendee engagement was great to see. Well done in the virtual setting!

Prof Shen-Yang Lim is discussing ongoing #Parkinsons clinical trial at the MDS 2020 virtual meeting, & began his talk by kindly highlighting the recent report in Journal of Parkinson's Disease by Kevin McFarthing SueB Gary Rafaloff & the Cure Parkinson's team:
content.iospress.com/articles/journ…

'Exchanged consent' - brilliant @Sparks4PD

Thank you, CPT, for all you do!

WOW! An overview & analysis of 2019-2020 clinical drug development pipeline for #Parkinsons - both symptomatic & disease modifying.

Amazing analysis of the clinical trial landscape from PD research (super) advocates Kevin McFarthing Sue Buff & Gary Rafaloff
content.iospress.com/articles/journ…